Yu Yumiao 余玉苗

余玉苗,1989年7月至1996年10月,在武汉大学经济学院审计系任助教、讲师;1996年11月至2001年10月,在武汉大学商学院会计系任副教授;2001年11月至今,在武汉大学经济与管理学院会计系任教授、博士生导师;2017年6月至2024年1月担任金域医学独立董事,2019年11月至2025年7月担任中安科的独立董事,2020年9月至今担任联特科技独立董事,2021年4月至今担任湖北宏泰集团外部董事,2022年8月至今担任广东融泰药业独立非执行董事,2025年7月至今担任人福医药独立董事,2022年6月至今,任禾元生物独立董事。

English Translation 英文译文 · Organisation Names in Chinese 机构名称保留中文Yu Yu Miao, from July 1989 to October 1996, was an assistant lecturer and lecturer in the School of Auditing at 武汉大学经济学院; From November 1996 to October 2001, Yu Yu Miao was an associate professor in the School of Accounting at 武汉大学商学院; From November 2001 to the present, Yu Yu Miao has been a professor and doctoral supervisor in the School of Accounting at 武汉大学经济与管理学院; From June 2017 to January 2024, Yu Yu Miao served as an independent director at 金域医学 (Kingmed Diagnostics), from November 2019 to July 2025 as an independent director at 中安科 (China Security), from September 2020 to the present as an independent director at 联特科技 (Linktel Technologies), from April 2021 to the present as an external director at 湖北宏泰集团, from August 2022 to the present as an independent non-executive director at Guangdong Rongtai Pharmaceutical, from July 2025 to the present as an independent director at Renfu Medical, and from June 2022 to the present as an independent director at 禾元生物 (Healthgen Biotech).